Home » CGT CDMO » Plasmid CDMO Services » GMPro^TM Plasmid Manufacturing

GMPro^TM Plasmid Manufacturing

Meet clinical trial expectations, ready for regulatory submission

Appropriate for viral vector and mRNA production

ProBio GMPro^TM Plasmid for research and development and clinical use of advanced therapy

GMPro^TM plasmid DNA is appropriate for the production of viral vectors or mRNA therapeutics. The whole process, manufacturing environment and documentation are strictly controlled under comprehensive quality assurance, guarantee the product quality and compliant for early clinical stages and research and development. We are also able to provide documentations for regulatory submissions.

ProBio is dedicated to providing one-stop solution from plasmid production to viral vector production (Lentiviral vector or AAV) to clients.
Plasmid for LVV

Plasmid in mRNA

Speed to Clinic

2~3 months fast delivery
Support regulatory submissions

Critical Quality Assurance

Phase Appropriate Compliance (PAC)
Customer Quality Verification (CQV)
Accumulated Experience
- Over 300 manufacturing batches for clinical trials
- Various downstream applications for CGT, mRNA vaccine, DNA vaccine, etc.
- Global clients from China, USA, Korea, etc.

More assays are included except for the ones listed below, and other options are available. Get a quote for more information.

GMPro^TM is a service trademark applied by ProBio